Skip to main content

Table 2 Association of CETRUS scores with the clinicopathologic characteristics of 77 patients with localized prostate cancer who underwent radical prostatectomy

From: Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer

Variables No. Low score (score ≤ 3) High score (score > 3) p
Age (years) 0.834
  ≤ 65 43 20 (46.5%) 23 (53.5%)  
  > 65 34 15 (44.1%) 19 (55.9%)  
Tumor stage 0.756
 T1N0M0 25 12 (48.0%) 13 (52.0%)  
 T2N0M0 52 23 (44.2%) 29 (55.8%)  
Gleason score 0.291
  ≤ 7 51 21 (41.2%) 30 (58.8%)  
  > 7 26 14 (53.8%) 12 (46.2%)  
PSA (ng/mL) 0.611
  < 15 46 22 (47.8%) 24 (52.2%)  
  ≥ 15 31 13 (41.9%) 18 (58.1%)  
BMI (kg/m2) 0.802
  < 25 43 19 (44.2%) 24 (55.8%)  
  ≥ 25 34 16 (47.1%) 18 (52.9%)  
ECOG PS 0.567
 0 51 22 (43.1%) 29 (56.9%)  
  ≥ 1 26 13 (50.0%) 13 (50.0%)  
 Total 77 35 (45.5%) 42 (54.5%)